NCT05010707
Transgender Estradiol Affirming Therapy
See it on ClinicalTrials.gov ↗39 people
100%
39 womenmiddle line = equal numbers0 men
- Phase
- PHASE2
- Paid for by
- Washington University School of Medicine
- Finished
- 2024-01-01
- Health conditions
- Transgenderism
- Who could join
- Men only
- Ages
- 18 Years – 30 Years
- Average age
- median 25.3 years
- Age 65+
- 0%
- Weight (BMI)
- mean 25.1 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Some results split by sex
- Race
- White 82.1% · Black / African American 7.7% · Asian 5.1% · Not reported 5.1% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0%
Women left out
- Men only
No women were allowed to join.
“Eligibility: Male participants only.”
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 30 Years.”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index \>30 kg/m2”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“History of liver disease”
- No smokers
Women who smoke or use nicotine were turned away.
“Cigarette smoking”
Study titles and rules are shown in their original English.